Introduction {#S1}
============

Physical activity has an important role in many aspects of treatment of people with type 1 diabetes ([@B32]). Recent meta-analysis did not show benefit of exercise as measured by HbA~1*c*~ ([@B30]), while other studies show inconsistent results ([@B7]). Large cross-sectional study of 18,028 adults with type 1 diabetes showed that people who engaged more in recreational exercise had better HbA~1*c*~ concentrations, a more favorable BMI, less dyslipidemia and hypertension, and fewer diabetes-related complications (retinopathy and microalbuminuria) than those who were less habitually active ([@B4]). A 7-year prospective cohort analysis performed in 1,659 people with type 1 diabetes could not find association between HbA~1*c*~ levels and amount of LTPA ([@B3]). In another cross-sectional study of 1,030 people with type 1 diabetes low levels of LTPA were associated with poor glycemic control in women, but there was no statistical association with levels of LTPA and HbA~1*c*~ in men ([@B36]).

Physical activity can be divided into structured PA and NEPA. NEPA is distinct from purposeful exercise and includes every PA that is not sleeping, eating, or sports-like exercise and includes various activities in daily life such as going to work, attending school, singing, dancing, washing clothes, cleaning floor, etc. NEAT represents the energy expenditure associated with these activities ([@B24]). The variety of different types of activity that composes total NEPA creates a challenge for assessment of NEAT. Researchers have tried to estimate NEPA/NEAT with the use of double labeled water, indirect calorimetry, accelerometer, pedometer, inclinometer, heart rate, and activity diary ([@B33]).

Amount of NEPA affects daily glucose excursions ([@B29]). Interrupting sitting time with short bouts of light or moderate intensity walking lowers postprandial glucose and insulin levels in overweight/obese adults ([@B14]). In people with type 1 diabetes, slow-pace walking after a meal improves postprandial glucose excursions when observed in controlled study environment ([@B26]). Routine daily PAs of everyday life seem to be coupled with glucose variations in type 1 diabetes ([@B16]). Recent study has successfully provided quantitative information on correlation between mild PA and short-term glucose dynamics in type 1 diabetes ([@B37]), that could be used in future models to improve glucose management with combination of advanced sensor technologies ([@B12]).

Majority of research that tries to study effects of PA on metabolic control in people with type 1 diabetes assesses predominantly planned exercise or LTPA. While higher levels of NEAT are known to be associated with many health benefits in people with type 2 or without diabetes ([@B25]), long-term metabolic effects of NEAT in people with type 1 diabetes have not been elucidated, yet. The aim of this study was to determine the association between different types of PA and metabolic control in people with type 1 diabetes.

Materials and Methods {#S2}
=====================

Sample and Study Protocol {#S2.SS1}
-------------------------

One hundred and nine adult people with documented type 1 diabetes, that agreed to participate in the study and signed a written consent, were consecutively enrolled in the study on their regular visit at outpatient diabetes clinic in University Medical Centre Ljubljana (from January to March 2018). People with substantial limitations for everyday PA or pregnancy were excluded from the study. One homeless person was also excluded, because his answers would be inappropriate for NEAT questionnaire in current form.

During the regular visits, body weight was measured using Seca 285 device (Seca GmbH, Germany), while blood pressure was obtained using automatic sphygmomanometer Omron M6 (Omron, Osaka, Japan). Blood samples were withdrawn for HbA~1*c*~ analysis using D-100 Bio-Rad high-performance liquid chromatography method (Bio-Rad Laboratories, United States), whereas serum lipid profile was retrieved from electronic health record, if they were collected routinely within 1 year before inclusion (available for 75 participants). The study protocol was approved by the National Medical Ethics Committee of Slovenia (Ref. No. 0120-258/2017/4).

Participants were asked to complete World Health Organization GPAQ ([@B2]) for assessment of MPA and VPA at work (such as paid or unpaid work, study/training, household chores, harvesting food/crops, fishing or hunting for food, and seeking employment), during traveling to and from places and during recreational activities. Duration of VPA per week in minutes (VPA) was calculated with the sum of VPA at work and recreation, whereas duration of MPA per week in minutes (MPA) was calculated with the sum of MPA at work, recreation, and transport.

Non-exercise activity thermogenesis was assessed with the questionnaire that was developed by [@B20] for assessment of NEAT in people with type 2 diabetes. The NEAT questionnaire consists of 11 question items about daily locomotive activities (about commuting on foot, shopping for food, using stairs, etc.) and 25 question items about non-locomotive activities (being active in different domestic chores, looking after children, elderly, or pets, etc.). Prior to NEAT questionnaire administration, question regarding the karaoke singing was changed to choir singing, which is a more common habit in Slovenian population. Each questionnaire item was then evaluated with a score of one to three points in order of levels of habitual PA as described in original paper and added up to determine the total NEAT score. NEAT questionnaire tries to indirectly assess the amount of activity of daily living that is not always perceived as PA in other questionnaires for assessing PA. Its use for this task was validated by triaxial accelerometer in people with type 2 diabetes ([@B19]). PA assessed by NEAT score partly overlaps with MPA assessed with GPAQ. Nevertheless, GPAQ has higher threshold for detecting PA while including only MPA that causes small increases in breathing or heart rate such as brisk walking (or carrying light loads) and also does not capture PA episodes shorter than 10 min.

Moreover, participants also reported the frequency of recent hypoglycemia. Frequency of hypoglycemia was defined with participant's self-estimated number of documented hypoglycemias (\<3.9 mmol/l) in the last month.

Statistical Analysis {#S2.SS2}
--------------------

Data were analyzed using IBM SPSS 21 (IBM Inc., Chicago, IL, United States). Categorical data are presented as numbers (percentages), and numerical variables are presented as means (standard deviations). All numerical data were screened for normality of distribution using Shapiro--Wilk's test and histograms. Correlations were calculated using Pearson's correlation coefficient for normally distributed and linear correlation, otherwise Spearman's rank correlation coefficient was applied. Additionally, the associations between demographic variables (sex, age, BMI), PA variables (NEAT, MPA, and VPA), and selected metabolic variables (HbA~1*c*~, frequency of hypoglycemia), hemodynamics, and blood lipids were determined using the multivariate linear regression, after the data were screened for normality of distribution, homoscedasticity, linearity, and multicollinearity ([@B17]). In the case of asymmetrically distributed outcome variable, the data were transformed using logarithmic (frequency of hypoglycemia, HDL) or 1/Y transformation (triglycerides, BMI, SBP). The significance level was set at *p*-values \< 0.05.

Results {#S3}
=======

A total of 109 people diagnosed with type 1 diabetes \[54 men and 55 women, aged 38 (10) years, height 173.7 (8.7) cm, and weight 77.33 (15.70) kg\] were included in the sample ([Table 1](#T1){ref-type="table"}), with mean type 1 diabetes duration of 22 (10) years. Majority of participants (65.1%) were regular users of insulin pump, 31% of them were also using CGMS. Thirty-five percent of the study participants used MDIs for glucose management, 13.2% of them used CGMS. Half of them failed to reach the goal for glycemic control \[median HbA~1*c*~ 53.0 mmol/mol (7.0%)\] and reported more than four events (median 4.0 events per month) of hypoglycemia per month. In addition to therapy for glucose control, some participants had prescribed anti-hypertensive (15.0%) and/or medication therapy for dyslipidemia (14.0%). We observed statistically significant differences in PA between genders, with men spending more time for VPA and women being more active in NEPA. Correlations of different types of PA with different observed parameters of metabolic control are presented in [Table 2](#T2){ref-type="table"} and multivariate regression models in [Table 3](#T3){ref-type="table"}.

###### 

Baseline sample characteristics.

                                       **All**           **Men**           **Women**         ***p*-value**   ***N***
  ------------------------------------ ----------------- ----------------- ----------------- --------------- ---------
  **Demographics**                                                                                           
  Gender, men/women (*n*)              109               54                55                                109
  Age (years)                          38 (10)           37 (9)            38 (10)           0.849           108
  Height (cm)                          173.72 (8.74)     179.43 (7.17)     167.69 (5.67)     \< 0.001        105
  Weight (kg)                          77.33 (15.70)     84.41 (13.04)     69.98 (14.93)     \< 0.001        106
  BMI (kg/m^2^)                        25.54 (4.57)      26.22 (3.78)      24.83 (5.23)      0.008           105
  **Diabetes characteristics**                                                                               
  Insulin pump -- *n* (%)              71 (65.1)         34 (63.0)         37 (67.3)         0.690           109
  CGMS -- *n* (%)                      27 (24.8)         16 (29.6)         11 (20.0)         0.274           109
  Duration of diabetes (years)         22 (10)           22 (11)           22 (10)           0.815           102
  Frequency of hypoglycemia (*n*)      6 (4)             6 (4)             6 (5)             0.888           99
  **Hemodynamics and blood markers**                                                                         
  Systolic blood pressure (mmHg)       129.64 (17.18)    135.81 (16.43)    123.10 (15.41)    \< 0.001        105
  Diastolic blood pressure (mmHg)      79.10 (8.75)      81.17 (8.81)      76.90 (8.21)      0.011           105
  HbA~1c~ (mmol/mol)                   53.28 (9.69)      53.86 (9.78)      52.69 (9.64)      0.346           106
  HbA~1c~ (%)                          7.03 (0.89)       7.08 (0.90)       6.97 (0.88)       0.346           106
  Serum cholesterol (mmol/L)           4.91 (0.73)       4.81 (0.66)       5.04 (0.80)       0.181           75
  Serum HDL (mmol/L)                   1.75 (0.50)       1.6 (0.41)        1.94 (0.54)       0.005           75
  Serum LDL (mmol/L)                   2.77 (0.62)       2.84 (0.64)       2.66 (0.58)       0.195           75
  Triglycerides (mmol/L)               0.92 (0.45)       0.99 (0.56)       0.84 (0.25)       0.157           75
  **Physical activity**                                                                                      
  MPA (min/week)                       688.2 (711.13)    680.80 (806.86)   695.38 (612.85)   0.180           104
  VPA (min/week)                       418.16 (649.45)   501.47 (696.40)   336.44 (595.28)   0.039           103
  NEAT score (points)                  73.14 (9.85)      70.55 (10.15)     75.74 (8.90)      0.006           106

BMI, body mass index; CGMS, continuous glucose monitoring system; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MPA, moderate physical activity; VPA, vigorous physical activity; NEAT, non-exercise activity thermogenesis; data are expressed as mean (

SD

).

p

value \< 0.05.

###### 

Correlations of PA types with clinical parameters and biomarkers.

                  **All**   **Men**   **Women**                                                            
  --------------- --------- --------- -------------- ----------- ---------------- ----------- ------------ -----------
  HbA~1c~         VPA       102       0.190          0.056       0.094            0.513       0.228        0.107
                  MPA       103       0.044          0.660       −0.014           0.925       0.095        0.503
                  NEAT      105       **0.226^‡^**   **0.021**   **0.286^‡^**     **0.038**   0.152        0.281
                                                                                                           
  Hypoglycemia    VPA       96        −0.201         0.050       −0.224           0.118       −0.202       0.178
                  MPA       96        −0.023         0.827       −0.055           0.708       −0.025       0.865
                  NEAT      98        −0.165         0.105       −0.120           0.401       −0.276       0.060
                                                                                                           
  SBP             VPA       101       **0.320**      **0.001**   0.211            0.137       **0.282**    **0.047**
                  MPA       102       0.169          0.089       0.211            0.137       0.268        0.057
                  NEAT      104       −0.150         0.127        **−0.273**^‡^   **0.048**   0.057        0.691
                                                                                                           
  DBP             VPA       101       0.056          0.575       −0.016           0.914       0.048        0.740
                  MPA       102       −0.017         0.866       0.007            0.960       0.033        0.819
                  NEAT      104        −0.124^‡^     0.211        −0.116^‡^       0.408        −0.006^‡^   0.968
                                                                                                           
  BMI             VPA       101       −0.008         0.934       0.002            0.988       −0.071       0.622
                  MPA       102       −0.175         0.079       −0.112           0.431       −0.167       0.241
                  NEAT      104       **−0.352**     **0.000**   **−0.411**       **0.002**   −0.202       0.154
                                                                                                           
  Cholesterol     VPA       73        **−0.234**     **0.046**   −0.240           0.130       −0.150       0.412
                  MPA       72        −0.123         0.303       −0.093           0.575       −0.144       0.424
                  NEAT      74         −0.203^‡^     0.082        −0.278^‡^       0.078       −0.252^‡^    0.157
                                                                                                           
  LDL             VPA       73        **−0.249**     **0.034**   **−0.344**       **0.028**   −0.261       0.149
                  MPA       72        −0.111         0.354       −0.104           0.530       −0.047       0.796
                  NEAT      74         −0.221^‡^     0.058        −0.228^‡^       0.151        −0.128^‡^   0.478
                                                                                                           
  HDL             VPA       72        −0.071         0.550       0.158            0.324       −0.093       0.612
                  MPA       71        −0.062         0.606       −0.083           0.613       −0.148       0.413
                  NEAT      73        −0.112         0.341        −0.158^‡^       0.323        −0.328^‡^   0.062
                                                                                                           
  Triglycerides   VPA       73        −0.036         0.764       −0.077           0.632       0.029        0.874
                  MPA       72        0.123          0.302       0.173            0.293       0.014        0.940
                  NEAT      74        0.174          0.138       **0.371**        **0.017**   −0.119       0.511

‡

Pearson's correlation coefficient.

r

, Spearman's correlation coefficient; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MPA, moderate physical activity; NEAT, non-exercise activity thermogenesis score; VPA, vigorous physical activity. Bold values indicate significant at

p

\< 0.05.

###### 

Multivariate regression models.

  **Dependent variable**   **Predictors**   **Multivariate regression model**   **Adjusted *R*^2^ (model *p*-value)**              
  ------------------------ ---------------- ----------------------------------- --------------------------------------- ---------- ------------------
  1/BMI                    Sex              --0.00159                           −0.00401, 0.00083                       0.194      0.165 (\< 0.001)
                           Age              --0.00013                           −0.00024, −0.00001                      0.035      
                           HbA~1c~          --0.00176                           −0.00310, −0.00042                      0.011      
                           NEAT             0.00021                             0.00008, 0.00034                        0.001      
                                                                                                                                   
  HbA~1c~                  Sex              0.226                               −0.104, 0.557                           0.177      0.168 (\< 0.001)
                           CGMS use         --0.455                             −0.826, −0.084                          0.017      
                           BMI              0.063                               0.027, 0.099                            \< 0.001   
                           NEAT             0.030                               0.013, 0.047                            \< 0.001   
                                                                                                                                   
  HbA~1c~                  Sex              --0.0054                            --0.3344.0.3236                         0.974      0.130 (0.001)
                           CGMS use         --0.3524                            −0.7384, 0.0336                         0.073      
                           BMI              0.0533                              0.0172, 0.0893                          0.004      
                           WORK             0.0002                              0.0001, 0.0004                          0.007      
                                                                                                                                   
  HbA~1c~                  Sex              0.1435                              −0.2041, 0.4911                         0.415      0.075 (0.021)
                           CGMS use         --0.4442                            −0.8406, −0.0479                        0.028      
                           BMI              0.0519                              0.0136, 0.0902                          0.009      
                           LEISURE          --0.0002                            −0.0008, 0.0004                         0.443      
                                                                                                                                   
  1/SBP                    Sex              --0.00061                           −0.00096, −0.00026                      \< 0.001   0.306 (\< 0.001)
                           BMI              --0.00010                           −0.00014, −0.00006                      \< 0.001   
                           NEAT             0.000002                            −0.00002, 0.00002                       0.830      
                                                                                                                                   
  1/SBP                    Sex              --0.00063                           −0.00096, −0.00030                      \< 0.001   0.348 (\< 0.001)
                           BMI              --0.00011                           −0.00015, −0.00007                      \< 0.001   
                           MPA              --0.0000003                         −0.00000, −0.00000                      0.009      
                                                                                                                                   
  1/SBP                    Sex              --0.000603                          −0.00094, −0.00027                      \< 0.001   0.349 (\< 0.001)
                           BMI              --0.000099                          −0.00014, −0.00006                      \< 0.001   
                           VPA              --0.0000003                         −0.000001, −0.00000                     0.012      
                                                                                                                                   
  Cholesterol              Sex              --0.230                             −0.565, 0.106                           0.177      0.086 (0.027)
                           BMI              0.00812                             −0.026, 0.042                           0.637      
                           VPA              --0.00034                           −0.001, −0.00009                        0.009      
                                                                                                                                   
  LDL                      Sex              0.17110                             −0.11030, 0.45250                       0.229      0.093 (0.021)
                           BMI              0.01087                             −0.01783, 0.03956                       0.452      
                           VPA              --0.0003                            −0.00052, −0.00001                      0.005      
                                                                                                                                   
  log(HDL)                 Sex              --0.101                             −0.154, −0.047                          \< 0.001   0.236 (\< 0.001)
                           BMI              --0.008                             −0.014, −0.003                          0.002      
                           NEAT             --0.004                             −0.006, −0.001                          0.008      
                                                                                                                                   
  log(HDL)                 Sex              --0.078                             −0.133, −0.022                          0.007      0.134 (0.006)
                           BMI              --0.007                             −0.012, −0.001                          0.021      
                           MPA              --0.000008                          −0.00004, 0.00002                       0.607      
                                                                                                                                   
  log(HDL)                 Sex              --0.072                             −0.124, −0.019                          0.009      0.172 (0.001)
                           BMI              --0.006                             −0.012, −0.001                          0.021      
                           VPA              --0.000041                          −0.00008, −0.000001                     0.043      

BMI, body mass index; CGMS, continuous glucose monitoring system; HDL, high-density lipoprotein; LDL, low-density lipoprotein; NEAT, non-exercise activity thermogenesis score; MPA, moderate physical activity; VPA, vigorous physical activity; LEISURE, total leisure PA; WORK, total work-related PA.

Glycemic Control {#S3.SS1}
----------------

There was a significant positive correlation between NEAT and HbA~1*c*~ when calculated for sample (*p* = 0.021) and sub-sample of men (*p* = 0.038), but not for women. Sub-analysis of people without usage of insulin pump or sensor technologies (*N* = 30) also showed positive correlation between HbA~1*c*~ and NEAT (*r* = 0.49; *p* = 0.006). Additionally, a tendency toward significant positive correlation was obtained between HbA~1*c*~ and VPA for the whole sample (*p* = 0.056). Furthermore, we obtained significant regression model explaining 16.8% of the variance of HbA~1*c*~ predicted from sex, BMI, CGMS use, and NEAT. Higher BMI and NEAT levels were significantly associated with higher levels of HbA~1*c*~, whereas in the same model the use of the CGMS significantly lowered HbA~1*c*~ levels. On the contrary, when NEAT was substituted for MPA or VPA in the regression model, there were no significant associations with HbA~1*c*~ (MPA *p* = 0.087, VPA *p* = 0.111). Total duration of work as assessed by GPAQ (moderate and vigorous) was significantly associated with HbA~1*c*~ (*p* = 0.007) when adjusted for sex, BMI, and CGMS use, while such associations were not significant with total duration of recreation as assessed by GPAQ (*p* = 0.443). Multivariate regression models predicting frequency of hypoglycemia with sex, HbA~1*c*~, and different types of PA were not significant, although there was a tendency toward significant negative correlation between VPA and frequency of hypoglycemia (*r* = −0.201, *p* = 0.050).

Body Weight and Blood Pressure {#S3.SS2}
------------------------------

Negative correlation between NEAT and BMI was obtained when performed for all participants (*r* = −0.352, *p* \< 0.001) and for sub-sample of men (*r* = −0.411, *p* = 0.002), also similar significant associations were observed in the multivariate models when controlled for sex, HbA~1c~, and age ([Table 3](#T3){ref-type="table"}). On the contrary, when NEAT was substituted by VPA and MPA, such associations with 1/BMI were not significant. There was a significant positive correlation between VPA and SBP when calculated for sample (*p* = 0.001) and sub-sample of women (*p* = 0.047), but not for men. SBP was positively associated with duration of MPA (*p* = 0.009) and VPA (*p* = 0.012), but not with NEAT score (*p* = 0.830) when controlled for sex and BMI, respectively. When the same multivariate models were applied for prediction of DBP, we failed to obtain significant models.

Serum Lipids {#S3.SS3}
------------

Correlations of serum lipids concentrations and different types of PA were significant only between VPA and total cholesterol (*r* = −0.234, *p* = 0.046) and LDL cholesterol (*r* = −0.249, *p* = 0.034), respectively. Sub-analysis in men showed significant correlations between VPA and LDL cholesterol (*r* = −0.344, *p* = 0.028) and also between NEAT and triglycerides (*r* = 0.371, *p* = 0.017).

When adjusted for sex and BMI, NEAT and VPA explained 23.6 and 17.2% of logHDL variance, respectively. Higher levels of NEAT and VPA were significantly associated with lower levels of logHDL, resulting in association with higher HDL levels (after the outcome was transformed using the inverse logarithm). When applying the same independent variables for predicting total cholesterol and LDL levels, there was a significant association with sex, BMI, and VPA, explaining 8.6% of variance of total cholesterol and 9.3% of LDL levels. Also, regression models adjusted for sex and BMI showed that higher values of VPA were significantly associated with lower levels of total cholesterol (*p* = 0.009) and LDL (*p* = 0.005).

Discussion {#S4}
==========

Physical activity has a potential to improve glucose metabolism in people with prediabetes and type 2 diabetes ([@B5]). This potential is hindered by a challenge of maintaining blood glucose within range with insulin therapy, that is especially demanding for persons with type 1 diabetes, who often do not achieve appropriate chronic glucose control ([@B28]). To maintain appropriate glycemic profile around PA they often have to keep their blood glucose higher, reduce their insulin dose, and/or increase consumption of carbohydrates, especially when PA is not planned in advance ([@B18]).

Results of our study failed to demonstrate benefit of LTPA on chronic glycemic control assessed by HbA~1c~ in people with type 1 diabetes. Furthermore, we demonstrated a positive association of NEAT score and total duration of work activity assessed with GPAQ with chronic glycemic control, with no significant association with frequency of self-reported hypoglycemia.

Majority of people with type 1 diabetes do not meet the exercise levels as recommended by guidelines ([@B28]). [@B11] observed relatively low levels of leisure time activity among adult Canadian population, with occupational and household activity accounting for \>80% of overall hours of daily PA. Low intensity PA of daily living constitutes about 20% of daily energy expenditure ([@B27]) and is usually of longer duration, more frequent, and unpredictable compared to planned exercise. High absolute burden of PA of daily living and work on efforts for self-management of glycemia could be one of the factors for positive association with HbA~1c~. Additionally, reducing inactivity by increasing the time spent walking/standing seems to be more effective in metabolic improvement than 1 h of physical exercise, when energy expenditure is kept constant ([@B15]).

Physical activity is frequently perceived as a significant risk of harm through hypoglycemia from perspective of people with diabetes ([@B6]). Fear of hypoglycemia is associated with higher HbA~1c~ levels ([@B1]) and could be one of the reasons for higher personal glycemic targets with insulin therapy while coping with daily glycemic imbalance associated with PA. HbA~1c~ is not the only indicator of glycemic control, because dynamic in glycemic variability may not be reflected in this measure ([@B34]). Data on influence of chronic effects of exercise training on glucose variability are still scarce, even if it represents one of the most robust predictors of hypoglycemia ([@B22]). One of the promising options for managing degree of glucose variability associated with PA are emerging modern technologies (sensors with adequate accuracy for exercise, modern insulin pumps, and improvement in insulin analogs) ([@B21]), while their use and association with NEAT still requires further studies for clarification.

Large proportion of people with type 1 diabetes is obese or overweight ([@B28]), which is in line with results from our sample. Emerging evidence suggests that obesity contributes to insulin resistance, dyslipidemia, and cardiometabolic complications in type 1 diabetes, while prevalence of obesity increases with alarming rate in this population ([@B10]). As expected from previous studies that emphasize the role of NEAT in preventing obesity ([@B31]), our results also suggest association of higher NEAT score with lower BMI in people with type 1 diabetes. Recent study by [@B13] shows a worrying trend in PA among US adults in years 2007--2016, with no improvement in duration of aerobic activity and statistically significant increase of sedentary behavior assessed by GPAQ. Recommendations on PA for weight management have traditionally been focused on leisure time activity, while other PA domains also offer many opportunities for interventions ([@B31]). Furthermore, there is a possible role of NEAT in behavioral compensation mechanisms after PA interventions that still awaits further clarification ([@B33]).

Predominant form of PA in people with type 2 diabetes are different domestic chores ([@B8]). It is therefore not surprising that NEAT score seems to be associated with amelioration in insulin sensitivity, waist circumference, HDL, blood pressure, and the markers for atherosclerosis in people with type 2 diabetes without hypoglycemic therapy ([@B20]). Limited research in type 1 diabetes suggests that interventions with exercise programs improve lipid levels, endothelial function, and insulin resistance but not blood pressure ([@B7]). Exercise training does not significantly change resting SBP according to the recent meta-analysis ([@B30]). Study of [@B4] did find an inverse association between LTPA and DBP without significant association with SBP. Surprisingly, we have observed a weak positive association of VPA and MPA with SBP in our sample when adjusted for sex and BMI, while we could not confirm such association with NEAT score. As expected from previous studies, our results also show positive association of NEAT score and VPA with HDL levels. Furthermore, we observed negative association of VPA with total and LDL cholesterol when adjusted for sex and BMI.

Because of relatively large sample size of our study, we could detect weak to moderate associations of sub-types of NEAT with different risk factors, which may have clinical implications in the population that has a known elevated risk for cardiovascular disease and sub-optimal risk factor control ([@B28]). Furthermore, frequent LTPA seems to reduce the risk of CVD events in people with type 1 diabetes in addition to traditional risk factors ([@B35]). Exercise has also been shown to improve immune system function, body composition, physiological well-being, cardiovascular fitness, and late complications of diabetes in people with type 1 diabetes ([@B9]; [@B23]). Further studies in type 1 diabetes are needed to evaluate the role of NEAT beyond traditional risk factors.

Our study has some important limitations, most important are cross-sectional design of the study and unspecific method (questionnaire) for estimating amount of NEAT. The validity of methods for measuring NEAT is still controversial. However, some authors believe that a questionnaire is one of the most useful and reliable methods of measuring NEAT at the moment ([@B20]). Nevertheless, there is a need for use and further development of more precise methods for estimating NEAT ([@B27]; [@B37]). Additional studies are also needed to exclude possible confounding variables (influence of diet, sociocultural background, and other factors) that may influence results of our analysis because of cross-sectional design of the study.

Conclusion {#S5}
==========

Higher NEAT score is associated with lower body weight and higher HDL in adult people with type 1 diabetes, but may also present an additional burden for them with more challenging environment regarding glycemic control. New strategies for people with type 1 diabetes with higher levels of NEAT should be developed in the future to strengthen the protective effect of NEPA with combating modern sitting environment and also tackling the problem of the potentially greater glucose variability. Methods for precise estimation of NEAT should be further developed because of important role of this "silent" part of energy expenditure in people with type 1 diabetes, that is often overlooked in research and also in clinical practice.
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BMI

:   body mass index

CGMS

:   continuous glucose monitoring system

DBP

:   diastolic blood pressure

GPAQ

:   global physical activity questionnaire

HDL

:   high-density lipoprotein

LDL

:   low-density lipoprotein

LTPA

:   leisure time physical activity

MDI

:   multiple daily injections

MPA

:   moderate physical activity

NEAT

:   non-exercise activity thermogenesis

NEPA

:   non-exercise physical activity

PA

:   physical activity

SBP

:   systolic blood pressure

VPA

:   vigorous physical activity
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